Poloxamer: A versatile tri-block copolymer for biomedical applications

P Zarrintaj, JD Ramsey, A Samadi, Z Atoufi, MK Yazdi… - Acta biomaterialia, 2020 - Elsevier
Poloxamers, also called Pluronic, belong to a unique class of synthetic tri-block copolymers
containing central hydrophobic chains of poly (propylene oxide) sandwiched between two …

Recent advances in mucoadhesive interface materials, mucoadhesion characterization, and technologies

IS Bayer - Advanced Materials Interfaces, 2022 - Wiley Online Library
Mucoadhesion is an extremely important field of adhesion science and the comprehensive
understanding and modulation of mucoadhesion can lead to lifesaving materials and …

Mucosal applications of poloxamer 407-based hydrogels: An overview

E Giuliano, D Paolino, M Fresta, D Cosco - Pharmaceutics, 2018 - mdpi.com
Poloxamer 407, also known by the trademark Pluronic® F127, is a water-soluble, non-ionic
triblock copolymer that is made up of a hydrophobic residue of polyoxypropylene (POP) …

Biomedical applications of biodegradable polymers

BD Ulery, LS Nair, CT Laurencin - Journal of polymer science …, 2011 - Wiley Online Library
Utilization of polymers as biomaterials has greatly impacted the advancement of modern
medicine. Specifically, polymeric biomaterials that are biodegradable provide the significant …

Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: A review

A Sosnik, J das Neves, B Sarmento - Progress in Polymer Science, 2014 - Elsevier
The presence of a mucus layer that covers the surface of a variety of organs has been
capitalized to develop mucoadhesive dosage forms that remain in the administration site for …

Mucoadhesive and thermogelling systems for vaginal drug delivery

CM Caramella, S Rossi, F Ferrari, MC Bonferoni… - Advanced drug delivery …, 2015 - Elsevier
This review focuses on two formulation approaches, mucoadhesion and thermogelling,
intended for prolonging residence time on vaginal mucosa of medical devices or drug …

New strategies for local treatment of vaginal infections

R Palmeira-de-Oliveira, A Palmeira-de-Oliveira… - Advanced drug delivery …, 2015 - Elsevier
Vaginal infections are extremely prevalent, particularly among women of reproductive age.
Although they do not result in high mortality rates, these infections are associated with high …

Recent advances in polymer-based vaginal drug delivery systems

T Osmałek, A Froelich, B Jadach, A Tatarek… - Pharmaceutics, 2021 - mdpi.com
The vagina has been considered a potential drug administration route for centuries. Most of
the currently marketed and investigated vaginal formulations are composed with the use of …

Strategies for prevention and treatment of Trichomonas vaginalis infections

K Bouchemal, C Bories, PM Loiseau - Clinical microbiology …, 2017 - Am Soc Microbiol
The last estimated annual incidence of Trichomonas vaginalis worldwide exceeds that of
chlamydia and gonorrhea combined. This critical review updates the state of the art on …

Formulation strategies to modulate drug release from poloxamer based in situ gelling systems

H Abdeltawab, D Svirskis, M Sharma - Expert Opinion on Drug …, 2020 - Taylor & Francis
Introduction: Poloxamer based in situ gelling systems offer numerous advantages in drug
delivery; however, their application as prolonged-release delivery platforms is limited mainly …